In contrast, previous reports have demonstrated that elderly patients with RA have higher serum levels of interleukin (IL-6), suggesting that IL-6-targeting therapy could be one of the viable therapeutic options in elderly patients with RA [18]. The gene discussed is IL6; the disease is rheumatoid arthritis.